Croivalve
Helping treat heart valve disease
Croivalve is a company in human health based in Ireland, founded in 2017.
Profile
CroíValve is developing a transcatheter device to treat Tricuspid Regurgitation, a common heart valve disorder for which there are no commercially-available, minimally-invasive solutions. CroíValve’s solution, invented by a leading interventional cardiologist, is a coaptation valve to restore tricuspid valve function by supporting the native valve leaflets. It is held in place by an atraumatic anchor that facilitates straightforward delivery and positioning while also preserving the cardiac anatomy.
Croivalve is positioned in human health, a segment that rewards a clear, focused offering.
The business is associated with Ireland.
Its current recorded stage is SOSV portfolio company.
Its team size is recorded as 11-50 employees.
It has disclosed roughly $4.5M in funding.
| Sector | Human Health |
|---|---|
| Country | Ireland |
| Founded | 2017 |
| Employees | 11-50 |
| Stage | SOSV portfolio company |
| Total funding | $4,500,000 |
Website: croivalve.com
Create a free account